Effect of supplementation in treatment of women with gestational diabetes
Phase 3
- Conditions
- Gestational diabetes.Diabetes mellitus in pregnancy, unspecifiedE28.2
- Registration Number
- IRCT201611115623N91
- Lead Sponsor
- Vice chancellor for research, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Patients with gestational diabetes
Aged 18 to 40 years.
Exclusion Criteria
Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Urinary tract infection
Smokers
Kidney or liver diseases
Insulin therapy during intervention
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Nitric oxide. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.
- Secondary Outcome Measures
Name Time Method